Dionex Corporation (Sunnyvale, California) announced that its next president, chief executive officer (CEO), and member of its board of directors will be Dr. Frank Witney, effecive April 30, 2009.
Dionex Corporation (Sunnyvale, California) announced that its next president, chief executive officer (CEO), and member of its board of directors will be Dr. Frank Witney, effecive April 30, 2009. Dr. Lukas Braunschweiler resigned as president and CEO to accept a new position as CEO of Ruag Holding AG, a Switzerland-based aviation, defense, and technology company. Witney reportedly has 25 years of experience in the life science and analytical instrumentation industry with companies such as Affymetrix, Panomics, PerkinElmer, and Bio-Rad. He was a postdoctoral fellow at the National Institutes of Health and holds a doctorate in molecular and cell biology from Indiana University.
LC–MS/MS-Based System Used to Profile Ceramide Reactions to Diseases
April 26th 2024Scientists from the University of Córdoba in Córdoba, Spain recently used liquid chromatography–tandem mass spectrometry (LC–MS/MS) to comprehensively profile human ceramides to determine their reactions to diseases.
High-Throughput 4D TIMS Method Accelerates Lipidomics Analysis
April 25th 2024Ultrahigh-pressure liquid chromatography coupled to high-resolution mass spectrometry (UHPLC-HRMS) had been previously proposed for untargeted lipidomics analysis, but this updated approach was reported by the authors to reduce run time to 4 min.